Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P.
Berghoff AS, et al. Among authors: steger gg.
Breast. 2014 Oct;23(5):637-43. doi: 10.1016/j.breast.2014.06.011. Epub 2014 Jul 10.
Breast. 2014.
PMID: 25017122
Free article.